Emergence of new forms of totally drug-resistant tuberculosis bacilli: Super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran

Chest

Volumn 136, Issue 2, 2009, Pages 420-425

  Velayati, Ali Akbar ^a   Masjedi, Mohammad Reza ^a   Farnia, Parissa ^a   Tabarsi, Payam ^a   Ghanavi, Jalladein ^b   ZiaZarifi, Abol Hassan ^a   Hoffner, Sven Eric ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL DNA; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG MEGADOSE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; FOLLOW UP; HUMAN; IMMIGRANT; IN VITRO STUDY; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SPUTUM SMEAR; TOTAL DRUG RESISTANT TUBERCULOSIS; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 68849127471     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2427     Document Type: Article

References (19)

1. World Health Organization (WHO). Stop TB partnership annual report 2004. Available at: http://whqlibdoc.who.int/hq/2005/WHO-HTM-STB-2005.33-eng.pdf. Accessed April 20, 2009
2. Masjedi MR, Farnia P, Sorooch S, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 2006; 43:841-847
3. Velayati AK, Farnia P, Mirsaeidi, et al. The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and Afghan TB cases. Scand J Infect Dis 2006; 38:463-468
4. Centers for Diseases Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second line drugs worldwide, 2000-2004. MMWR Morb Wkly Rep 2006; 55:301-305
5. Lawn SD, Wilkinson R. Extensively drug resistant tuberculosis. BMJ 2006; 333:559-560
6. Blass SH, Mutterlein R, Weig J, et al. Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases. BMC Infect Dis 2008; 8:60-67
7. Zignol M, Hosseini M, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194:479-485
8. World Health Organization. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 2000. Geneva, Switzerland: World Health Organization, 2000; 1-250
9. Grant A, Gothard P, Thwaites G. Managing drug resistant tuberculosis. BMJ 2008; 337:1110-1117
10. Mirsaeidi MS, Tabarsi P, Farnia P, et al. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran. Saudi Med J 2007; 28:544-550
11. Kent PT, Kubica GP. Public health mycobacteriology: a guide for a level III laboratory. Atlanta, GA: Public Health Services, U.S. Department of Health and Human Services, 1985
12. Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-plus. Geneva, Switzerland: World Health Organization, 2001. Available at: http://whqlibdoc.who.int/hq/2001/WHO-CDS-TB- 2001.288.pdf. Accessed April 20, 2009.
13. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendation for a standardized methodology. J Clin Microbiol 1993; 31:406-409
14. Frothingham R, Meeker-O'Connell W. Genetic diversity in the MTB complex based on variable numbers of tandem DNA repeats. Microbiology 1998; 144:1189-1196
15. Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998; 2:10-15
16. Farnia P, Masjedi MR, Mirsaeidi M, et al. Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients. J Infect 2006; 53:331-336
17. Farnia P, Masjedi MR, Varahram M, et al. The recent transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping [abstract]. BMC Infect Dis 2008; 8:109
18. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (spolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6:23-50
19. Moszynski P. Doctors disagree over detention of patients with extensively drug resistant tuberculosis [abstract]. BMJ 2007; 334:228